UJJIVANSFBBSEUJJIVAN SMALL FINANC BANKCriticalNegative
Announced Tue, 1 Sept, 2026 · 11:54 IST

Ujjivan SFB MD & CEO Sanjeev Nautiyal takes early retirement, Carol Furtado named acting chief

Ceo ResignedKmp ResignedManagement Changes View source PDFExplain this filing

UJJIVANSFB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-5.9%Reaction day
₹69.32
prior close
₹68.64
announcement price
In-mkt
timing
Nifty Microcap 250market-1.0%-4.9% vs market
Other Bank peers, median of 8sector-1.6%-4.2% vs sector

On the reaction day the stock moved 4.9 pts less than Nifty Microcap 250 and 4.2 pts less than its Other Bank peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.1
10m
-0.1
15m
-0.1
30m
-0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-5.9-1.0-4.9-1.6-4.2
Next day
-7.5-1.5-5.9-1.2-6.3
2d
-9.2-0.9-8.3-1.2-8.0
3d
-6.9-0.3-6.7-1.0-5.9
4d
-6.1+0.1-6.3-1.0-5.1
5d
-6.4+0.7-7.1-0.5-5.9
1w
-4.1+0.3-4.4-2.8-1.3
15d
-4.7+1.0-5.7-2.9-1.8
1m
-5.4-2.4-3.0-7.6+2.2
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Other Bank peers, median of 8Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ujjivan Small Finance Bank's MD & CEO Mr. Sanjeev Nautiyal has opted for early retirement citing health issues. The board accepted his request; he stepped down from the MD & CEO role on September 1, 2026, serving a notice period until November 30, 2026, after a 2 plus year stint. Existing Executive Director Ms. Carol Furtado, with over 30 years of banking experience, has been appointed acting MD & CEO from September 1, 2026, subject to RBI approval. The board will search for a permanent successor.

Likely market impact

Health-driven early exit of MD & CEO; experienced insider named acting chief easing transition, but successor search adds short-term uncertainty.